Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 23, 2022Journal of Neurology Neurosurgery & PsychiatryOpen Access

SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis

View Full Paper
Ask AI
Bookmark
Share

Authors

ZKZoé L. E. van KempenVrije Universiteit AmsterdamESEileen W StalmanAmsterdam NeuroscienceMSMaurice SteenhuisSanquin

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kempen et al. (2022) studied this question.

synapsesocial.com/papers/69dd5a248557d5ab8f40d1f0https://doi.org/10.1136/jnnp-2022-330100
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis2021 · 243 citations
  2. 2Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study2022 · 908 citations
  3. 3Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination2022 · 85 citations
  4. 4COVID ‐19 Vaccine Response in People with Multiple Sclerosis2021 · 153 citations
  5. 5Dynamics of antibodies to SARS‐CoV‐2 in convalescent plasma donors2021 · 69 citations